CVR number 39387468
Industry 32.5000 Manufacture of medical and dental instruments and supplies

Bandagist Vest ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  2.2% 2.2% 2.2% 2.2% 2.2%  
Bankruptcy risk  3.2% 1.1% 1.1% 1.6% 1.9%  
Credit score (0-100)  57 84 82 74 69  
Credit rating  BBB A A A A  
Credit limit (kDKK)  0.0 87.3 68.6 3.7 0.5  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  2,300 3,070 3,184 3,327 2,914  
EBITDA  471 1,160 710 606 119  
EBIT  300 941 488 383 -32.3  
Pre-tax profit (PTP)  298.6 933.4 475.6 370.7 -47.3  
Net earnings  232.6 726.6 371.0 288.4 -38.9  
Pre-tax profit without non-rec. items  299 933 476 371 -47.3  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  729 730 535 312 161  
Shareholders equity total  351 1,078 1,049 1,037 798  
Interest-bearing liabilities  90.7 9.9 378 678 601  
Balance sheet total (assets)  1,805 2,084 2,512 2,347 2,117  
Net Debt  -392 -548 -148 142 -352  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  2,300 3,070 3,184 3,327 2,914  
Gross profit growth  25.5% 33.5% 3.7% 4.5% -12.4%  
Employees  3 4 4 4 4  
Employee growth %  0.0% 33.3% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,805 2,084 2,512 2,347 2,117  
Balance sheet change%  83.4% 15.5% 20.5% -6.6% -9.8%  
Added value  471.0 1,159.6 710.3 605.9 119.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  124 -218 -418 -445 -303  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 3.0 4.0 5.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  13.1% 30.6% 15.3% 11.5% -1.1%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  21.6% 48.4% 21.2% 15.8% -1.4%  
ROI %  53.7% 118.3% 38.1% 24.3% -2.0%  
ROE %  56.3% 101.7% 34.9% 27.6% -4.2%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  19.5% 51.7% 41.8% 44.2% 37.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -83.3% -47.3% -20.8% 23.5% -294.8%  
Gearing %  25.8% 0.9% 36.0% 65.3% 75.3%  
Net interest  0 0 0 0 0  
Financing costs %  1.7% 16.6% 6.3% 2.4% 2.5%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.7 1.4 1.2 1.5 1.3  
Current Ratio  0.8 1.7 1.5 1.6 1.5  
Cash and cash equivalent  483.1 558.0 525.9 535.4 953.4  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -334.8 525.8 614.7 774.8 609.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  157 290 178 151 30  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  157 290 178 151 30  
EBIT / employee  100 235 122 96 -8  
Net earnings / employee  78 182 93 72 -10